2023-16716. National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting  

  • Start Preamble

    Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering.

    The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the contact person listed below in advance of the meeting. In person attendees should register at ( https://www.nibib.nih.gov/​about-nibib/​advisory-council/​registration) in advance of the meeting so that the meeting organizers can plan accordingly.

    The meeting will be videocast and can be accessed from the NIH Videocasting website at ( https://videocast.nih.gov/​watch=​51083).

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering, NACBIB, September 2023.

    Date: September 14, 2023.

    Open: 09:00 a.m. to 12:20 p.m.

    Agenda: Report from the Institute Director, Council Members and other Institute Staff.

    Place: National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Room 1135/45/55, Rockville, MD 20852.

    Closed: 2:00 p.m. to 4:00 p.m.

    Agenda: To review and evaluate grant applications and/or proposals.

    Place: National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Room 1135/45/55, Rockville, MD 20852.

    Contact Person: Kathy Salaita, Ph.D., Acting Associate Director for Research Administration, Office of Research Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Bethesda, MD 20892, kathy.salaita@nih.gov.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Information is also available on the Institute's/Center's home page: https://www.nibib.nih.gov/​about-nibib/​advisory-council where an agenda and any additional information for the meeting will be posted when available.

    Start Signature

    Dated: August 1, 2023.

    Victoria E. Townsend,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2023–16716 Filed 8–4–23; 8:45 am]

    BILLING CODE 4140–01–P

Document Information

Published:
08/07/2023
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2023-16716
Dates:
September 14, 2023.
Pages:
52189-52189 (1 pages)
PDF File:
2023-16716.pdf